ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.81
1.18%
US Dollar vs MXN
16.97343
0.01%
Brent Oil
82.85
-0.93%
Bitcoin
62,009.58
4.90%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) Noticias

WGS GeneDx Holdings Corporation

19.85
0.35 (1.79%)
Última actualización: 14:46:10
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
GeneDx Holdings Corporation WGS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.35 1.79% 19.85 14:46:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
19.47 19.09 21.71 19.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202415:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/4/202407:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
04/4/202415:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/3/202407:30GLOBEGeneDx to Present Data at the 2024 American College of..
05/3/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
23/2/202415:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202415:28EDGAR2Form 8-K - Current report
20/2/202415:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
01/2/202415:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
24/1/202415:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
23/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:58EDGAR2Form 8-K - Current report
08/1/202407:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
04/1/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202320:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202307:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
28/11/202315:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
20/11/202315:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
17/11/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202315:33EDGAR2Form 8-K - Current report
30/10/202315:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
23/10/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202315:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
03/10/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202315:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
19/9/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202307:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
06/9/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202307:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21/8/202306:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
08/8/202319:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
08/8/202315:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202315:13EDGAR2Form 8-K - Current report
08/8/202315:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07/8/202307:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
27/7/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202316:04EDGAR2Form 8-K - Current report
21/7/202320:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202306:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..

Su Consulta Reciente

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados